Teva to buy Allergan generic drug business for $40.5 billion, drops Mylan bid

TEL AVIV (Reuters) – Teva Pharmaceutical Industries has agreed to buy Allergan Plc’s generic drugs business for $40.5 billion in a cash and stock deal that will turn the Israeli company into one of the world’s largest pharmaceutical firms.



Source: Business

Leave a Reply

Your email address will not be published. Required fields are marked *

five × 2 =